Elpiscience Announces CDE Clearance of IND Application for Anti-CD39 Monoclonal Antibody ES002
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--#CD39--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical…